Protein Microarray Market Research Report- Forecast till 2027

Protein Microarray Market Research Report: By Type (Chips, Microfluidics, Integrated Systems), Application (Diagnostics, Proteomics, Antibody Characterization, Functional Analysis), Product, Technology, End User- Forecast till 2023

ID: MRFR/LS/3868-HCR | | Region: Global | 90 pages

Protein Microarray Market Scenario


Protein microarray, also known as protein chips, is an emerging class of proteomic technology that is becoming a critical tool in biochemistry and molecular biology. It is miniaturized and parallel assay system that contain small amounts of purified samples for distinguishing different types of proteins. The development of efficient and advanced diagnosis technology, rising awareness among people regarding personalized medicine, increasing government initiative across the globe, growing prevalence and incidences of cancer across the globe are majorly driving the growth of the global protein microarray market.

Proteomics instruments, reagents, and testing are needed to discover new biomarkers and even new drugs. The market has crossed 5 billion dollars in 2013. Though a number of tests are available in the market for protein analysis, the microarray is the efficient and fastest revenue generating technique. Improvement in generating high-quality proteins and antibodies will play a key role in the quantitative analysis and promote the extension of this technology to other organisms.

Despite the considerable investments made by several companies, the low availability of proteins in the market. Proteins are highly sensitive to changes in their microenvironment. This presents a challenge in maintaining protein arrays in a stable condition over extended periods of time. Declining production of consistent and reliable proteins due to low yield may hamper the market growth over the forecast period 2017-2023.

The protein microarray global market is expected to grow at a CAGR of approximately 8.2% during the forecast period 2017-2023.


Key Players


Some of key the players in the global protein microarray market are Thermo Fisher Scientific (U.S), Agilent Technologies (U.S.), F. Hoffmann-La Roche AG (Genentech) (Switzerland), Illumina Inc. (U.S.), Abbott Laboratories (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), SEQUENOM, Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Affymetrix, Inc. (U.S.), EMD Millipore (U.S.), Medtronic Inc. (U.S.), Angioscore Ltd. (U.S.) and others.


Segmentation


The global protein microarray is segmented on the basis of type, application, product, technology, and end-users.


On the basis of the type, the global protein microarray market is segmented into protein chips, lab-on-chips (microfluidics), integrated systems, arrayers, and microarray systems.


On the basis of the application, the global protein microarray market is segmented into diagnostics, proteomics, protein functional analysis, and antibody characterization.


On the basis of the product, the global protein microarray market is segmented into protein microarray instruments, protein microarray reagents, and protein microarray services.


On the basis of the technology, the global protein microarray market is segmented into analytical microarrays, functional protein microarrays, and reverse phase protein microarray


On the basis of the end user, the global protein microarray market has been segmented into hospitals, clinics, diagnostic centers, academic institutes, research centers, and others.


Regional Analysis


The global protein microarray market consists of countries namely America, Europe, Asia Pacific, and the Middle East & Africa.

The Americas are projected to hold the largest share of the global protein microarray market. Moreover, U.S. dominated the overall market in terms of revenue in 2017. National expenditures on cancer care in the United States was USD ~125 billion in 2010 and could reach USD 156 billion by 2020. According to the American Cancer Society in 2017, approximately 16, 88,780 new cases of cancer were believed to be diagnosed. The high incidence rate of cancer, increase in awareness about this condition, rise in focus on healthcare, and well-established healthcare infrastructure is some of the factors driving the North American market growth.

Europe holds the second largest share of the global protein microarray treatment market attributed to changing lifestyle and increasing R&D activities for the development of new drugs. The European protein microarray market is expected to show a rapid growth during the forecast period.

The Asia Pacific is estimated to be the fastest growing region during the forecast period due to increasing government funding, rising awareness among people regarding personalized medicine, growing prevalence and incidence rate of cancer. Additionally, increasing adoption of protein chip in emerging economies such as China, India, and others is likely to create new opportunities for the protein microarray market. The Middle East & African market is projected to expand during the forecast period owing to the rising investments by the market players and increasing adoption of protein microarrays for diagnostic purpose.

Research Methodology Protein Microarray Market


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Protein Biochip Manufacturers

  • Protein Microarray Distributors

  • Pharmaceutical Companies

  • Biotechnology Companies

  • Research Institutes

  • Academic Institutes

  • Contract Research Organizations

  • Research And Consulting Companies



Report Scope:
Report Attribute/Metric Details
  Market Size   2027:Significant Value
  CAGR   2017-2023: 8.2%
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, application, product, technology, and end-users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific (U.S), Agilent Technologies (U.S.), F. Hoffmann-La Roche AG (Genentech) (Switzerland), Illumina Inc. (U.S.), Abbott Laboratories (U.S.), PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), SEQUENOM, Inc. (U.S.), Sigma Aldrich Corporation (U.S.), Affymetrix, Inc. (U.S.), EMD Millipore (U.S.), Medtronic Inc. (U.S.), Angioscore Ltd. (U.S.) and others
  Key Market Opportunities   New biomarkers and new drugs
  Key Market Drivers

  • Rising awareness among people regarding personalized medicine
  • Increasing government initiative across the globe


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    Global protein microarray market is expected to expand at 8.2% CAGR from 2017 to 2023.

    Awareness of personalized medicine among patients and development of advanced diagnostic services are major drivers of the global protein microarray market.

    Discovery of novel biomarkers and development of novel drugs can bolster the global protein microarray market growth.

    The Americas is expected to dominate global protein microarray market till 2023 due to North America contributing to its revenue.

    Medtronic Inc., GE Healthcare, Bio-Rad Laboratories Inc., Agilent Technologies, Angioscore Ltd., Thermo Fisher Scientific, F. Hoffmann-La Roche AG, EMD Millipore, Abbott Laboratories, Illumina Inc., PerkinElmer Inc., Affymetrix, Inc., SEQUENOM, Inc., Fluidigm Corporation, Sigma Aldrich Corporation, and Cepheid Inc. are prominent players of the global protein microarray market.

    TABLE OF CONTENT

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porter’s Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Protein Microarray Market, by Type

    6.1 Introduction

    6.2 Protein chips

    6.2.1 Market Estimates & Forecast, 2020 – 2027

    6.3 Lab-on-chips (microfluidics)

    6.3.1 Market Estimates & Forecast, 2020 – 2027

    6.4 Integrated systems

    6.4.1 Market Estimates & Forecast, 2020 – 2027

    6.5 Arrayers

    6.5.1 Market Estimates & Forecast, 2020 – 2027

    6.6 Microarray systems

    6.6.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 7. Global Protein Microarray Market, by Application

    7.1 Introduction

    7.2 Diagnostics

    7.2.1 Market Estimates & Forecast, 2020-2027

    7.3 Proteomics

    7.3.1 Market Estimates & Forecast, 2020-2027

    7.4 Protein functional analysis

    7.4.1 Market Estimates & Forecast, 2020-2027

    7.5 Antibody characterization

    Chapter 8. Global Protein Microarray Market, by Product

    8.1 Introduction

    8.2 Protein microarray instruments

    8.2.1 Market Estimates & Forecast, 2020-2027

    8.3 Protein microarray reagents

    8.3.1 Market Estimates & Forecast, 2020-2027

    8.4 Protein microarray services

    8.4.1 Market Estimates & Forecast, 2020-2027

    Chapter 9. Global Protein Microarray Market, by Technology

    9.1 Introduction

    9.2 Analytical microarrays

    9.2.1 Market Estimates & Forecast, 2020-2027

    9.3 Functional protein microarrays

    9.3.1 Market Estimates & Forecast, 2020-2027

    9.4 Reverse phase protein microarray

    9.4.1 Market Estimates & Forecast, 2020-2027

    Chapter 10. Global Protein Microarray Market, by End User

    10.1 Introduction

    10.2 Hospitals

    10.2.1 Market Estimates & Forecast, 2020-2027

    10.3 Clinics

    10.3.1 Market Estimates & Forecast, 2020-2027

    10.4 Diagnostic Centers

    10.4.1 Market Estimates & Forecast, 2020-2027

    10.5 Academic Institutes

    10.5.1 Market Estimates & Forecast, 2020-2027

    10.4 Research centers

    10.4.1 Market Estimates & Forecast, 2020-2027

    10.5 Others

    10.5.1 Market Estimates & Forecast, 2020-2027

    Chapter. 11 Global Protein Microarray Market, by Region

    11.1 Introduction

    11.2 Americas

    11.2.1 North America

    11.2.1.1 U.S.

    11.2.1.1 Canada

    11.2.2 South America

    11.3 Europe

    11.3.1 Western Europe

    11.3.1.1 Germany

    11.3.1.2 France

    11.3.1.3 Italy

    11.3.1.4 Spain

    11.3.1.5 U.K

    11.3.1.6 Rest of Western Europe

    11.3.2 Eastern Europe

    11.4 Asia Pacific

    11.4.1 Japan

    11.4.2 China

    11.4.3 India

    11.4.4 Australia

    11.4.5 Republic of Korea

    11.4.6 Rest of Asia Pacific

    11.5 The Middle East & Africa

    11.5.1 United Arab Emirates

    11.5.2 Saudi Arabia

    11.5.3 Rest of the Middle East & Africa

    Chapter 12 Company Landscape

    12.1 Introduction

    12.2 Market Share Analysis

    12.3 Key Development & Strategies

    12.3.1 Key Developments

    Chapter 13 Company Profiles

    13.1 GE Healthcare

    13.1.1 Company Overview

    13.1.2 Product Overview

    13.1.3 Financials

    13.1.4 SWOT Analysis

    13.2 Thermo Fisher Scientific

    13.2.1 Company Overview

    13.2.2 Product Overview

    13.2.3 Financial Overview

    13.2.4 Key Developments

    13.2.5 SWOT Analysis

    13.3 Bio-Rad Laboratories Inc.

    13.3.1 Company Overview

    13.3.2 Product Overview

    13.3.3 Financial Overview

    13.3.4 Key Development

    13.3.5 SWOT Analysis

    13.4 Agilent Technologies

    13.4.1 Company Overview

    13.4.2 Product/Business Segment Overview

    13.4.3 Financial Overview

    13.4.4 Key Development

    13.4.5 SWOT Analysis

    13.5 PerkinElmer Inc.

    13.5.1 Company Overview

    13.5.2 Product Overview

    13.5.3 Financial overview

    13.5.4 Key Developments

    13.6 Cepheid Inc.

    13.6.1 Company Overview

    13.6.2 Product Overview

    13.6.3 Financial Overview

    13.6.4 Key Developments

    13.7 Fluidigm Corporation

    13.7.1 Overview

    13.7.2 Product Overview

    13.7.3 Financials

    13.7.4 Key Developments

    13.7.5 SWOT Analysis

    13.8 F. Hoffmann-La Roche Ltd

    13.8.1 Company Overview

    13.8.2 Product/Business Segment Overview

    13.8.3 Financial Overview

    13.8.4 Key Development

    13.8.5 SWOT Analysis

    13.9 Illumina Inc.

    13.9.1 Company Overview

    13.9.2 Product Overview

    13.9.3 Financial overview

    13.9.4 Key Developments

    13.10 Others

    Chapter 14 MRFR Conclusion

    14.1 Key Findings

    14.1.1 From CEO’s View Point

    14.1.2 Unmet Needs of the Market

    14.2 Key Companies to Watch

    14.3 Prediction of Pharmaceutical industry

    Chapter 15 Appendix

    LIST OF TABLES

    Table 1 Protein Microarray Industry Synopsis, 2020-2027

    Table 2 Protein Microarray Market Estimates and Forecast, 2020-2027, (USD Million)

    Table 3 Protein Microarray Market by Region, 2020-2027, (USD Million)

    Table 4 Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 5 Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 6 Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 7 Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 8 Protein Microarray Market by End Users, 2020-2027, (USD Million)

    Table 9 North America Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 10 North America Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 11 North America Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 12 North America Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 13 North America Protein Microarray Market by End User, 2020-2027, (USD Million)

    Table 14 US Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 15 US Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 16 US Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 17 US Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 18 US Protein Microarray Market by End User, 2020-2027, (USD Million)

    Table 19 Canada Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 20 Canada Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 21 Canada Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 22 Canada Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 23 Canada Protein Microarray Market by End User, 2020-2027, (USD Million)

    Table 24 South America Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 25 South America Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 26 South America Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 27 South America Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 28 South America Protein Microarray Market by End User, 2020-2027, (USD Million)

    Table 29 Europe Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 30 Europe Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 31 Europe Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 32 Europe Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 33 Europe Protein Microarray Market by End User, 2020-2027, (USD Million)

    Table 34 Western Europe Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 35 Western Europe Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 36 Western Europe Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 37 Western Europe Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 38 Western Europe Protein Microarray Market by End User, 2020-2027, (USD Million)

    Table 39 Eastern Europe Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 40 Eastern Europe Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 41 Eastern Europe Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 42 Eastern Europe Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 43 Eastern Europe Protein Microarray Market by End User, 2020-2027, (USD Million)

    Table 44 Asia Pacific Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 45 Asia Pacific Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 46 Asia Pacific Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 47 Asia Pacific Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 48 Asia Pacific Protein Microarray Market by End User, 2020-2027, (USD Million)

    Table 49 The Middle East & Africa Protein Microarray Market by Type, 2020-2027, (USD Million)

    Table 50 The Middle East & Africa Protein Microarray Market by Application, 2020-2027, (USD Million)

    Table 51 The Middle East & Africa Protein Microarray Market by Product, 2020-2027, (USD Million)

    Table 52 The Middle East & Africa Protein Microarray Market by Technology, 2020-2027, (USD Million)

    Table 53 The Middle East & Africa Protein Microarray Market by End User, 2020-2027, (USD Million)

    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Protein Microarray Market

    Figure 3 Segmentation Market Dynamics for Protein Microarray Market

    Figure 4 Global Protein Microarray Market Share, by Type 2020

    Figure 5 Global Protein Microarray Market Share, by Application 2020

    Figure 6 Global Protein Microarray Market Share, by Product, 2020

    Figure 8 Global Protein Microarray Market Share, by Technology, 2020

    Figure 9 Global Protein Microarray Market Share, by End Users, 2020

    Figure 10 Global Protein Microarray Market Share, by Region, 2020

    Figure 11 North America Protein Microarray Market Share, by Country, 2020

    Figure 12 Europe Protein Microarray Market Share, by Country, 2020

    Figure 13 Asia Pacific Protein Microarray Market Share, by Country, 2020

    Figure 14 The Middle East & Africa Protein Microarray Market Share, by Country, 2020

    Figure 15 Global Protein Microarray Market: Company Share Analysis, 2020 (%)

    Figure 16 GE Healthcare: Key Financials

    Figure 17 GE Healthcare: Segmental Revenue

    Figure 18 GE Healthcare: Geographical Revenue

    Figure 19 Thermo Fisher Scientific: Key Financials

    Figure 20 Thermo Fisher Scientific: Segmental Revenue

    Figure 21 Thermo Fisher Scientific: Geographical Revenue

    Figure 22 Bio-Rad Laboratories Inc.: Key Financials

    Figure 23 Bio-Rad Laboratories Inc.: Segmental Revenue

    Figure 24 Bio-Rad Laboratories Inc.: Geographical Revenue

    Figure 25 Agilent Technologies: Key Financials

    Figure 26 Agilent Technologies: Segmental Revenue

    Figure 27 Agilent Technologies: Geographical Revenue

    Figure 28 PerkinElmer Inc.: Key Financials

    Figure 29 PerkinElmer Inc.: Segmental Revenue

    Figure 30 PerkinElmer Inc.: Geographical Revenue

    Figure 32 Cepheid Inc.: Key Financials

    Figure 33 Cepheid Inc.: Segmental Revenue

    Figure 34 Cepheid Inc.: Geographical Revenue

    Figure 35 Fluidigm Corporation: Key Financials

    Figure 36 Fluidigm Corporation: Segmental Revenue

    Figure 37 Fluidigm Corporation: Geographical Revenue

    Figure 38 F. Hoffmann-La Roche Ltd: Key Financials

    Figure 39 F. Hoffmann-La Roche Ltd: Segmental Revenue

    Figure 40 F. Hoffmann-La Roche Ltd: Geographical Revenue

    Figure 41 Illumina Inc.: Key Financials

    Figure 42 Illumina Inc.: Segmental Revenue

    Figure 43 Illumina Inc.: Geographical Revenue